Form 4: Definitive Healthcare Director Samuel Hamood Acquires Over 55,000 Shares in RSU Grant

Definitive Healthcare Corp. Director Samuel A. Hamood reported the acquisition of 55,911 shares of Class A Common Stock through a restricted stock unit grant, increasing his total beneficial ownership.

Summary

• Samuel A. Hamood, a Director of Definitive Healthcare Corp. (DH), acquired 55,911 shares of Class A Common Stock on June 5, 2025.
• These shares were acquired as Restricted Stock Units (RSUs) with a price of $0, indicating a grant rather than a cash purchase.
• The RSUs are set to vest on the earlier of June 5, 2026, or the date of the Issuer's next annual meeting of stockholders, contingent on Mr. Hamood's continued service.
• Following this transaction, Mr. Hamood directly beneficially owns 100,206 shares of Class A Common Stock.
• Additionally, he indirectly beneficially owns 51,582 shares through AMHAM DH LLC.
• The filing clarifies that 14,545 shares held by AMHAM DH LLC were inadvertently allocated to Mr. Hamood's direct holdings in a previous Form 4 filed on May 24, 2024, indicating a correction in reporting.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even through a grant, generally indicates confidence and aligns insider interests with shareholders. The correction of a previous reporting error also adds to transparency.

Positives

• The acquisition of 55,911 shares by a director, even through a grant, indicates continued alignment of management interests with shareholders.
• The grant of Restricted Stock Units (RSUs) is a common form of executive compensation, aligning long-term incentives with company performance and retention.

Risks

• The vesting of the 55,911 Restricted Stock Units is subject to the reporting person's continued service through the applicable vesting date, meaning the shares are not immediately liquid and could be forfeited if service ceases before vesting.

Future Outlook

The vesting schedule for the acquired Restricted Stock Units (RSUs) extends to June 5, 2026, or the next annual meeting, indicating a future milestone for the full realization of these shares, contingent on continued service.

Management Comments

• The filing includes a clarification regarding 14,545 shares previously misallocated to direct holdings in a prior Form 4, indicating a correction in reporting.

Industry Context

This Form 4 filing reflects routine insider compensation practices within the healthcare technology sector, where equity grants like RSUs are commonly used to incentivize and retain key executives and directors, aligning their interests with long-term company performance and shareholder value creation.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) at a $0 price is a standard practice for equity compensation in publicly traded companies across various industries, including healthcare technology.
• This method is widely adopted by peers in the healthcare IT space, such as Veeva Systems, IQVIA, and Oracle Health (formerly Cerner), to align executive incentives with shareholder value creation over a vesting period.
• The specific vesting terms (earlier of a fixed date or next annual meeting, subject to continued service) are also typical for such grants, ensuring retention and performance alignment, consistent with global benchmarks for executive compensation.

Related Party Transactions

• Indirect beneficial ownership of 51,582 shares through AMHAM DH LLC, which is a related entity to the reporting person.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders due to equity ownership, potentially fostering long-term value creation.
• Employees: No direct impact on general employees, but reflects standard compensation practices for senior leadership, which can influence overall compensation philosophy.

Next Steps

• Vesting of the 55,911 Restricted Stock Units on the earlier of June 5, 2026, or the next annual meeting of stockholders, subject to continued service.

Key Dates

Keywords

Definitive Healthcare Corp., DH, Samuel A. Hamood, Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Grant, Beneficial Ownership, Director Compensation, SEC Filing